The push is on to determine if the copious dollars expended to fund CME programs nationally actually translate to better patient care. The buzz phrase in the CME world these days is “outcomes measurement,” i.e., the role continuing medical...

When one of her pharma clients was launching a new injectable drug to help stimulate white blood cells to fight infection in chemotherapy patients, Clare O'Boyle, director of entertainment, United States, for Jack Morton Worldwide, New York, chose...

The Permanente Medical Group of the Kaiser Permanente health plan organization, which operates in nine states and Washington, D.C., recently updated its conflict-of-interest policy for its more than 5,000 Northern California physicians to make it...

CME IS ON THE FEDERAL radar screen once again. This time the U.S. Senate is investigating pharma companies' educational grants, including funding for CME. In June, Sens. Chuck Grassley (R-Iowa) and Max Baucus (D-Montana) sent letters to...